Inovio Pharmaceuticals Inc (INO) Stock Price Today
Aura AI Summary
Key Stats
- $97.91MMarket Cap
- -Volume
- HealthSector
- $2.8752W High
- $1.0552W Low
- -Typical Hold Time
- $68.92MEnterprise Value
- -Div Yield
- -Trading Activity
Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Most Recent News
Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...

Alamar Biosciences showcases over 140 presentations on blood-based Alzheimer's biomarkers at AAIC 2026.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...

Meta pauses Instagram AI image feature after privacy backlash
Meta has halted a new AI feature on Instagram that generated images using public account photos without user consent, following widespread privacy and copyright concerns. The feature was automatically enabled for public profiles, sparking criticism f...
